The effect of intraperitoneal administration of BromAc on blood parameters: phase 1 study

Intraperitoneal administration of BromAc (bromelain + acetylcysteine) is currently undergoing a phase 1 clinical trial for pseudomyxoma peritonei at our institution. This study reports on analysis of routine blood parameters before and after treatment for a series of 25 patients in this trial. Blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Kevin, Pillai, Krishna, Mekkawy, Ahmed H., Akhter, Javed, Badar, Samina, Valle, Sarah J., Morris, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777505/
https://www.ncbi.nlm.nih.gov/pubmed/35201475
http://dx.doi.org/10.1007/s12672-021-00418-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777505/
https://www.ncbi.nlm.nih.gov/pubmed/35201475
http://dx.doi.org/10.1007/s12672-021-00418-5

Ejemplares similares